-
Good news! Scientists have discovered two potent human antibodies that can neutralize more than 90% of known global HIV strains from infecting human cells in the laboratory, and they have demonstrated how one of these disease-fighting proteins achieves this action.
-
Your next patient is a recently divorced 48-year-old mother of two. Her menstrual periods have become somewhat irregular, and she reports occasional hot flashes and night sweats.
-
The search for a female-controlled form of HIV prevention just took a giant step. Results of a Phase IIB trial of a tenofovir gel indicate that use of the gel before and after sex provided moderate protection against sexually transmitted HIV.
-
Male pattern baldness treated with oral dutasteride; Home-based diagnosis of sleep apnea; What is the risk of bariatric surgery?; Comparing insulin and incretins; Which is better: COX2 or NSAID plus PPI?; Combination therapy to prevent DM2
-
A recent report described a fatal case of community-acquired C. difficile diarrhea (CDAD) in a patient receiving antibiotics for a questionable diagnosis of chronic Lyme disease.
-
A retrospective cohort study was conducted of infants < 6 months of age hospitalized with urinary tract infections between 1999 and 2004 at 24 children's hospitals in the United States.
-
In March 2009, 89 active-duty u.s. trainees received yellow fever (YF) vaccination as part of standard preparation for potential travel to sub-Saharan Africa and Central and South America.
-
A retrospective observational study was conducted on 30 individuals from a possible 49 persons who were treated for schistosomiasis between 2003 and 2008 at Copenhagen University Hospital, Denmark.
-
This subset analysis from a larger prospective, multicenter HIV-HCV coinfection treatment trial found that patients receiving highly active antiretroviral therapy (HAART) in combination with pegylated interferon alfa and ribavirin for HCV were at greater risk for lactic acidosis and hyperlactatemia than those receiving HCV treatment alone.
-
In this issue: Lorcaserin submitted for FDA review, FDA advisory panel votes against phentermine/topiramate, mixed vote on rosiglitazone, advisory panel votes to remove breast cancer indication from bevacizumab labeling, no increase in seizures found with DTaP vaccine, new REMS for quinine.
